265
20.
Kuo MY, Goldberg J, Coates L, Mason W, Gerin J, Taylor J. Molecular cloning of
hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure,
and applications. J Virol. 1988 Jun;62(6):1855-61.
21.
Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet. 2011 Jul
2;378(9785):73-85.
22.
Polson AG, Bass BL, Casey JL. RNA editing of hepatitis delta virus antigenome by
dsRNA-adenosine deaminase. Nature. 1996 Apr 4;380(6573):454-6.
23.
Glenn JS, Watson JA, Havel CM, White JM. Identification of a prenylation site in
delta virus large antigen. Science. 1992 May 29;256(5061):1331-3.
24.
Tseng CH, Cheng TS, Shu CY, Jeng KS, Lai MM. Modification of small hepatitis
delta virus antigen by SUMO protein. J Virol. 2010 Jan;84(2):918-27.
25.
Tacke F, Manns MP, Trautwein C. Influence of mutations in the hepatitis B virus
genome on virus replication and drug resistance--implications for novel antiviral
strategies. Curr Med Chem 2004; 11: 2667-77
26.
Huang CR, Lo SJ. Hepatitis D virus infection, replication and cross-talk with the
hepatitis B virus. World J Gastroenterol. 2014 Oct 28;20(40):14589-97.
27.
Vietheer PT, Netter HJ, Sozzi T, Bartholomeusz A. Failure of the lamivudine-
resistant rtM204I hepatitis B virus mutants to efficiently support hepatitis delta virus
secretion. J Virol 2005; 79: 6570-3
28.
Jenna S, Sureau C. Mutations in the carboxyl-terminal domain of the small hepatitis
B virus envelope protein impair the assembly of hepatitis delta virus particles. J
Virol 1999; 73: 3351-8
29.
Gudima S, Chang J, Moraleda G, Azvolinsky A, Taylor J. Parameters of human
hepatitis delta virus genome replication: the quantity, quality, and intracellular
distribution of viral proteins and RNA. J Virol 2002; 76: 3709-19
30.
Schaper M, Rodriguez-Frias F, Jardi R, Tabernero D, Homs M, Ruiz G, et al.
Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B
virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and
D. J Hepatol 2010; 52: 658-64
31.
Dastgerdi ES, Herbers U, Tacke F. Molecular and clinical aspects of hepatitis D
virus infections. World J Virol. 2012 June 12; 1(3): 71-8
32.
Abou-Jaoudé G, Sureau C. Entry of hepatitis delta virus requires the conserved
cysteine residues of the hepatitis B virus envelope protein antigenic loop and is
blocked by inhibitors of thiol-disulfide exchange. J Virol. 2007 Dec;81(23):13057-
66.
33.
Engelke M, Mills K, Seitz S, Simon P, Gripon P, Schnölzer M, et al. Characterization
of a hepatitis B and hepatitis delta virus receptor binding site. Hepatology. 2006;
43: 750-60
34.
Huang WH, Chen YS, Chen PJ. Nucleolar targeting of hepatitis delta antigen
abolishes its ability to initiate viral antigenomic RNA replication. J Virol. 2008; 82:
692-9
35.
Kuo MY, Sharmeen L, Dinter-Gottlieb G, Taylor J. Characterization of self-cleaving
RNA sequences on the genome and antigenome of human hepatitis delta virus. J
Virol. 1988 Dec;62(12):4439-44.
36.
Hampel A, Tritz R. RNA catalytic properties of the minimum (-) sTRSV sequence.
Biochemistry. 1989 Jun 13;28(12):4929-33.
37.
Haussecker D, Cao D, Huang Y, Parameswaran P, Fire AZ, Kay MA. Capped small
RNAs and MOV10 in human hepatitis delta virus replication. Nat Struct Mol Biol
2008; 15: 714-21
Hepatit Delta Virüsünün Moleküler Virolojisi
